Back to results
US 10,245,268 B2Granted
Treatment of ACVR1-mediated diseases
AssigneeSierra Oncology, Inc.
InventorsBrian Koh, Igor Theurl, Matthew Robert Warr, James Andrew Whitney
Life of this patent
Estimating the term…
Abstract
Provided herein are methods, compositions, and kits for treating ACVR-1-mediated diseases using N-(cyanomethyl)-4-[2-4-morpholinoanilino)pyrimidin-4-yl]benzamide.
Claims18
A method of treating an ACVR1-mediated disease comprising administering momelotinib or a pharmaceutically acceptable salt or solvate thereof to a patient in need thereof, wherein the ACVR1-mediated disease is selected from the group consisting of fibrodysplasia ossificans progressive (FOP) and diffuse intrapontine glioma (DIPG).
Dependencies are inferred from the claim text.